The cost-effectiveness of a new statin (rosuvastatin) in the UK NHS. [electronic resource]
Producer: 20040322Description: 792-800 p. digitalISSN:- 1368-5031
- Coronary Disease -- prevention & control
- Cost-Benefit Analysis
- Decision Support Techniques
- Drug Costs
- Fluorobenzenes -- economics
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- economics
- Models, Statistical
- Monte Carlo Method
- Pyrimidines -- economics
- Rosuvastatin Calcium
- State Medicine -- economics
- Sulfonamides -- economics
- United Kingdom
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.